Thanks to new regulatory frameworks like the Food and Drug Administration’s Breakthrough Therapy designation, drugs are coming to market faster than ever. A 2024 analysis of drugs included in this ...

Today’s health care leaders are awash in data. There’s no shortage of organizations collecting, structuring, and licensing massive real-world data sets, each touting millions of de-identified “patient ...

Delayed IPF diagnosis often results in significant lung function impairment, impacting patient outcomes and increasing hospitalization rates. Antifibrotic therapies, nintedanib and pirfenidone, are ...

Well before the term “personalized medicine” first appeared, the notion of healthcare tailored to the individual loomed on ...

Mayo Clinic clinicians are starting to explore how they might use healthcare-specific large language models – accessed through a generative artificial intelligence chat application – to enhance ...

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific, the world leader in serving science, today announced a strategic data collaboration with Datavant, the data collaboration platform trusted ...

The life sciences industry currently has access to more real-world data (RWD) than at any point in its history. Open claims, closed payer claims, EMR, lab, specialty pharmacy and biomarkers — and yet, ...

New research shows patients commonly take lower doses of nintedanib, and the majority are also taking immunomodulatory drugs. Real-world data on usage of the tyrosine kinase inhibitor nintedanib (Ofev ...

The majority of patients with early-stage disease Alzheimer’s disease (AD) had stable or improved cognition over roughly 1 year of treatment with lecanemab (Leqembi), a real-world analysis showed. The ...

Google is turning its vast public data trove into a goldmine for AI with the debut of the Data Commons Model Context Protocol (MCP) Server — enabling developers, data scientists, and AI agents to ...